ICD-11 code 1F82 refers to the diagnosis of fascioliasis, a parasitic infection caused by liver flukes of the Fasciola species. Fascioliasis is typically acquired by consuming contaminated water or aquatic plants containing the parasite’s larvae. Once ingested, the larvae travel to the liver where they mature into adult flukes, causing symptoms such as abdominal pain, fever, and jaundice.
The diagnosis of fascioliasis is confirmed through a combination of clinical evaluation, imaging studies (such as ultrasound), and laboratory tests to detect antibodies or parasite eggs in the stool. Treatment of fascioliasis usually involves medications to kill the parasite, such as triclabendazole. Early detection and treatment are key to preventing complications of fascioliasis, such as liver damage or bile duct blockage.
Preventative measures against fascioliasis include avoiding the consumption of raw or undercooked aquatic plants, as well as ensuring access to safe drinking water sources. Public health initiatives aimed at controlling the spread of fascioliasis may include monitoring and treating livestock, as they can serve as reservoirs for the parasite. Overall, awareness of the risk factors and symptoms of fascioliasis is essential for timely diagnosis and management of this parasitic infection.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
SNOMED CT code 398302006 is the equivalent code for the ICD-11 code 1F82, which corresponds to the diagnosis of Fascioliasis. Fascioliasis is a parasitic infection caused by liver flukes of the Fasciola genus, typically Fasciola hepatica and Fasciola gigantica. These flukes infect humans through the consumption of contaminated water plants such as watercress or by ingesting metacercariae present on the surface of freshwater plants.
It is important for healthcare professionals to accurately code and document cases of Fascioliasis using the SNOMED CT code 398302006 to ensure consistency in electronic health records and facilitate data exchange between healthcare providers. This standardized coding system helps streamline the process of diagnosis, treatment, and monitoring of patients with Fascioliasis, allowing for efficient communication and coordination of care across different healthcare settings.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of Fascioliasis, caused by the parasite Fasciola hepatica, can manifest in various ways, primarily affecting the liver and bile ducts. In the acute phase, patients commonly experience symptoms such as fever, abdominal pain, and hepatomegaly. Hepatitis-like symptoms may also be present, including jaundice and elevated liver enzymes.
Chronic fascioliasis is characterized by a milder, more prolonged course of symptoms. Patients may exhibit nonspecific symptoms such as fatigue, generalized abdominal pain, and weight loss. Biliary obstruction can occur due to the presence of the parasite in the bile ducts, leading to symptoms like cholangitis and cholecystitis.
In some cases, fascioliasis can also present with extrahepatic manifestations. Pulmonary symptoms such as cough and chest pain may occur if the parasite migrates to the lungs. Additionally, allergic reactions to the migrating larvae can lead to symptoms like urticaria and eosinophilia. These varied symptoms make diagnosis challenging and highlight the importance of considering fascioliasis in patients with unexplained liver or pulmonary symptoms.
🩺 Diagnosis
Diagnosis of fascioliasis can be challenging due to its nonspecific symptoms. In the acute phase, patients may present with fever, abdominal pain, and eosinophilia. In the chronic phase, symptoms can include hepatomegaly, chronic abdominal pain, and biliary colic.
Laboratory tests are crucial in the diagnosis of fascioliasis. Blood tests may reveal elevated liver enzymes, eosinophilia, or a positive immunodiagnostic test. Stool examination for eggs is also a common method of diagnosis, although eggs may not always be present in the stool.
Imaging studies such as ultrasound or CT scan can help identify liver abnormalities caused by the parasite. Serological tests, such as ELISA, can also be used to detect antibodies against Fasciola spp. in the blood. A definitive diagnosis may require a combination of these diagnostic methods to accurately confirm fascioliasis.
💊 Treatment & Recovery
The treatment for 1F82 (Fascioliasis) typically involves the use of medication to kill the parasites causing the infection. Commonly prescribed drugs include triclabendazole and bithionol, which are effective in targeting the liver flukes responsible for the condition. These medications work by disrupting the parasites’ ability to reproduce and survive within the body, ultimately leading to their elimination.
In addition to medication, supportive care may also be necessary to manage symptoms and complications associated with fascioliasis. This may include medication to relieve symptoms such as abdominal pain, fever, and fatigue, as well as monitoring of liver function to assess the severity of the infection and guide treatment decisions. In cases where complications such as liver abscesses or bile duct obstruction occur, additional interventions may be required to address these issues and prevent further harm to the patient.
Recovery from fascioliasis can vary depending on the severity of the infection and the effectiveness of treatment. In many cases, patients respond well to medication and experience a gradual improvement in symptoms over time. However, in some instances, complications or resistance to treatment may prolong the recovery process. It is important for patients with fascioliasis to follow their healthcare provider’s recommendations for treatment and monitoring closely to ensure a successful outcome. Regular follow-up appointments may be necessary to assess progress and address any ongoing issues related to the infection.
🌎 Prevalence & Risk
In the United States, 1F82, also known as fascioliasis, is considered to be a rare infection. Cases have been documented in various states, but the incidence is typically low compared to other countries. The prevalence of 1F82 is higher in regions where sheep and cattle farming are common, as these animals can be hosts for the parasite responsible for the infection.
In Europe, 1F82 is more commonly reported, particularly in areas with a high concentration of livestock farming. Countries such as France, Spain, and the United Kingdom have documented cases of fascioliasis among both animals and humans. The prevalence of the infection can vary significantly between regions within Europe, depending on factors such as climate, agricultural practices, and access to clean water sources.
In Asia, 1F82 is considered to be endemic in several countries, particularly in regions where rice farming is prevalent. Countries such as China, Iran, and Vietnam have reported high numbers of human cases of fascioliasis, often linked to the consumption of contaminated water plants. The prevalence of 1F82 in Asia is influenced by factors such as socioeconomic status, access to healthcare, and public health policies aimed at controlling the spread of the parasite.
In Africa, 1F82 is also endemic in certain regions, with countries such as Egypt, Sudan, and Ethiopia reporting cases of human infection. The prevalence of fascioliasis in Africa is often linked to factors such as water contamination, poor sanitation, and limited access to healthcare services. Efforts to control and prevent the spread of 1F82 in Africa are ongoing, with a focus on improving water quality, promoting hygiene practices, and implementing deworming programs for livestock.
😷 Prevention
To prevent 1F82 (Fascioliasis), it is essential to avoid consumption of contaminated water or plants that may be infected with the parasite responsible for the disease. This can be achieved through proper hygiene practices, such as washing fruits and vegetables thoroughly before consumption, and avoiding drinking water from potentially contaminated sources.
Additionally, controlling the population of snails, which serve as intermediate hosts for the parasite, can help prevent the transmission of 1F82. This can be done through measures such as using molluscicides to eliminate snails in water sources, or modifying habitats to make them less favorable for snail breeding.
Furthermore, proper animal husbandry practices can help prevent the spread of 1F82 to humans. This includes deworming animals regularly to reduce the risk of them being infected with the parasite, and being cautious when grazing animals in areas where contaminated water sources are present. By taking these preventive measures, the risk of contracting 1F82 can be significantly reduced.
🦠 Similar Diseases
Fascioliasis, coded as 1F82 by the 11th Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11), is a parasitic infection caused by liver flukes of the genus Fasciola. While closely related diseases may share similarities in symptoms or transmission methods, they are distinct entities in terms of etiology and clinical manifestations.
One such disease is schistosomiasis, coded as 1F86 in the ICD-11. Like fascioliasis, schistosomiasis is a parasitic infection that affects the liver and other organs. However, it is caused by a different type of parasitic worm known as a schistosome. The symptoms and treatment of schistosomiasis may overlap with those of fascioliasis, but proper diagnosis is essential for effective management.
Another relevant disease to consider is clonorchiasis, coded as 1F85 in the ICD-11. Clonorchiasis is caused by ingestion of raw or undercooked freshwater fish contaminated with the parasite Clonorchis sinensis. This parasite also affects the liver and can lead to similar symptoms as fascioliasis, including abdominal pain, nausea, and jaundice. Proper identification of the causative agent is crucial for appropriate treatment and prevention strategies.
Additionally, opisthorchiasis, coded as 1F83 in the ICD-11, is another liver fluke infection that shares some similarities with fascioliasis. Opisthorchis viverrini and Opisthorchis felineus are the parasites responsible for causing opisthorchiasis, which is acquired through ingestion of infected raw or undercooked fish. While the clinical presentation of opisthorchiasis may be similar to that of fascioliasis, distinct differences exist in the life cycle and geographic distribution of the causative agents. Accurate diagnosis and targeted treatment are essential for managing these related parasitic diseases.